Mr. Kokesh is the founder of ViCardia Therapeutics, Inc. Prior work experience includes serving as the Chief Executive Officer of the Ischemia Research and Education Foundation, a leading cardiovascular institute. Mr. Kokesh has been an executive officer, founder or co-founder of four successful, institutional venture capital financed medical technology and healthcare services companies.
Education: B.A./B.S. (Distributive Major: Molecular Biology, Political Science, and English Literature) from the University of Colorado at Boulder and a Juris Doctor from the University of California – Hastings College of Law, San Francisco. Member of the California Bar Association and a Fellow of the American Bar Foundation.
Education: B.A./B.S. (Distributive Major: Molecular Biology, Political Science, and English Literature) from the University of Colorado at Boulder and a Juris Doctor from the University of California – Hastings College of Law, San Francisco. Member of the California Bar Association and a Fellow of the American Bar Foundation.
-
Mr. Kokesh is the founder of ViCardia Therapeutics, Inc. Prior work experience includes serving as the Chief Executive Officer of the Ischemia Research and Education Foundation, a leading cardiovascular institute. Mr. Kokesh has been an executive officer, founder or co-founder of four successful, institutional venture capital financed medical technology and healthcare services companies.
Education: B.A./B.S. (Distributive Major: Molecular Biology, Political Science, and English Literature) from the University of Colorado at Boulder and a Juris Doctor from the University of California – Hastings College of Law, San Francisco. Member of the California Bar Association and a Fellow of the American Bar Foundation.
Michael Kokesh, J.D.
President & CEO
Dr. Herskowitz, in 2010, founded Antara Medical, based in San Francisco, a world-class integrative medicine team approach towards prevention and treatment of vascular, immunologic and difficult chronic diseases such as acute heart failure syndrome. During his 12 years at Johns Hopkins, he became Associate Professor of Medicine and Immunology and Molecular Microbiology and led a research team in the study of molecular and immunological mechanisms of inflammation, autoimmunity, ischemia, heart transplantation rejection and congestive heart failure. Dr. Herskowitz co-founded The Institute for OneWorld Health in 2000 and served as its Chief Medical Officer. Dr. Herskowitz has extensive experience performing large-scale multinational phase II and III clinical trials. Prior to co-founding iOWH, he directed all multinational clinical trials at the Ischemia Research & Education Foundation, including all epidemiologic and outcome studies and registries. Dr Herskowitz was also named a Clinical Professor of Medicine at UC San Francisco for 15 years, in the Division of Cardiology.
Education: MD degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and Fellowship training in Cardiology at The Johns Hopkins Medical Center.
Education: MD degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and Fellowship training in Cardiology at The Johns Hopkins Medical Center.
-
Dr. Herskowitz, in 2010, founded Antara Medical, based in San Francisco, a world-class integrative medicine team approach towards prevention and treatment of vascular, immunologic and difficult chronic diseases such as acute heart failure syndrome. During his 12 years at Johns Hopkins, he became Associate Professor of Medicine and Immunology and Molecular Microbiology and led a research team in the study of molecular and immunological mechanisms of inflammation, autoimmunity, ischemia, heart transplantation rejection and congestive heart failure. Dr. Herskowitz co-founded The Institute for OneWorld Health in 2000 and served as its Chief Medical Officer. Dr. Herskowitz has extensive experience performing large-scale multinational phase II and III clinical trials. Prior to co-founding iOWH, he directed all multinational clinical trials at the Ischemia Research & Education Foundation, including all epidemiologic and outcome studies and registries. Dr Herskowitz was also named a Clinical Professor of Medicine at UC San Francisco for 15 years, in the Division of Cardiology.
Education: MD degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and Fellowship training in Cardiology at The Johns Hopkins Medical Center.
Ahvie Herskowitz, M.D.
Chief Medical & Scientific Officer
Dr. Bayrhoffer, a physician by training, is a successful executive with a background in clinical development, strategy consulting, and financial advisory. After starting his career at The Boston Consulting Group, Dr. Bayrhoffer attained global leadership positions with life-science companies in Europe, US, India, and Latin America. As an accomplished entrepreneur, he has successfully advanced innovative technologies in the life sciences from concept to product launch.
Education: PhD/MD degree from the University of Mainz, Germany; MBA from the Simon School of Business, University of Rochester, NY.
Education: PhD/MD degree from the University of Mainz, Germany; MBA from the Simon School of Business, University of Rochester, NY.
-
Dr. Bayrhoffer, a physician by training, is a successful executive with a background in clinical development, strategy consulting, and financial advisory. After starting his career at The Boston Consulting Group, Dr. Bayrhoffer attained global leadership positions with life-science companies in Europe, US, India, and Latin America. As an accomplished entrepreneur, he has successfully advanced innovative technologies in the life sciences from concept to product launch.
Education: PhD/MD degree from the University of Mainz, Germany; MBA from the Simon School of Business, University of Rochester, NY.
Thilo Bayrhoffer, M.D., M.B.A.
Chief Operating Officer
Michael Kokesh, J.D.
President & CEO
Mr. Kokesh is the founder of ViCardia Therapeutics, Inc. Prior work experience includes serving as the Chief Executive Officer of the Ischemia Research and Education Foundation, a leading cardiovascular institute. Mr. Kokesh has been an executive officer, founder or co-founder of four successful, institutional venture capital financed medical technology and healthcare services companies.
Education: B.A./B.S. (Distributive Major: Molecular Biology, Political Science, and English Literature) from the University of Colorado at Boulder and a Juris Doctor from the University of California – Hastings College of Law, San Francisco. Member of the California Bar Association and a Fellow of the American Bar Foundation.
Education: B.A./B.S. (Distributive Major: Molecular Biology, Political Science, and English Literature) from the University of Colorado at Boulder and a Juris Doctor from the University of California – Hastings College of Law, San Francisco. Member of the California Bar Association and a Fellow of the American Bar Foundation.
Ahvie Herskowitz, M.D.
Chief Medical & Scientific Officer
Dr. Herskowitz, in 2010, founded Antara Medical, based in San Francisco, a world-class integrative medicine team approach towards prevention and treatment of vascular, immunologic and difficult chronic diseases such as acute heart failure syndrome. During his 12 years at Johns Hopkins, he became Associate Professor of Medicine and Immunology and Molecular Microbiology and led a research team in the study of molecular and immunological mechanisms of inflammation, autoimmunity, ischemia, heart transplantation rejection and congestive heart failure. Dr. Herskowitz co-founded The Institute for OneWorld Health in 2000 and served as its Chief Medical Officer. Dr. Herskowitz has extensive experience performing large-scale multinational phase II and III clinical trials. Prior to co-founding iOWH, he directed all multinational clinical trials at the Ischemia Research & Education Foundation, including all epidemiologic and outcome studies and registries. Dr Herskowitz was also named a Clinical Professor of Medicine at UC San Francisco for 15 years, in the Division of Cardiology.
Education: MD degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and Fellowship training in Cardiology at The Johns Hopkins Medical Center.
Education: MD degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and Fellowship training in Cardiology at The Johns Hopkins Medical Center.
Thilo Bayrhoffer, M.D., M.B.A.
Chief Operating Officer
Dr. Bayrhoffer, a physician by training, is a successful executive with a background in clinical development, strategy consulting, and financial advisory. After starting his career at The Boston Consulting Group, Dr. Bayrhoffer attained global leadership positions with life-science companies in Europe, US, India, and Latin America. As an accomplished entrepreneur, he has successfully advanced innovative technologies in the life sciences from concept to product launch.
Education: PhD/MD degree from the University of Mainz, Germany; MBA from the Simon School of Business, University of Rochester, NY.
Education: PhD/MD degree from the University of Mainz, Germany; MBA from the Simon School of Business, University of Rochester, NY.
